bit.bio, the global leader in cell programming technology, today announced the successful closing of a $30 million financing round led by M&G Investments, a leading international savings and investment company.
ACS Guidelines Expand Lung Cancer Screening Eligibility — Is That a Good Thing?
BOSTON — Whether low-dose CT screening for lung cancer should be expanded to include people who quit smoking more than 15 years ago, as the
October 12, 2024